Glucosa Y Cloruro De Sodio, Viaflo Baxter (Sodium Chloride, Glucose)

Viaflo Baxter is indicated for several clinical situations where fluid, electrolyte, and energy replacement are required.

• Fluid and electrolyte replacement in patients with dehydration or losses from surgery, trauma, or gastrointestinal disorders.
• Treatment of hypoglycemia when rapid glucose delivery is needed.
• Component of parenteral nutrition regimens to provide carbohydrate calories.
• Support during diagnostic or therapeutic procedures that require intravenous fluid administration.
• Maintenance of plasma volume in perioperative care.

Adverse reactions to Glucosa Y Cloruro De Sodio are generally related to the infusion itself or to the individual components.

Common

• Mild local irritation or pain at the injection site.
• Transient increase in blood glucose levels.
• Electrolyte shifts causing mild hypernatremia or hyponatremia.
• Nausea or vomiting related to rapid infusion.

Serious

• Severe hyperglycemia in patients with uncontrolled diabetes.
• Fluid overload leading to pulmonary edema.
• Allergic reaction such as urticaria, bronchospasm, or anaphylaxis.

Clinicians should evaluate patient-specific factors before administering Glucosa Y Cloruro De Sodio to minimize risks.

• Assess baseline electrolyte levels and glucose concentration, especially in patients with renal or cardiac disease.
• Adjust infusion rate in individuals at risk for fluid overload or pulmonary edema.
• Use caution in patients with known hypersensitivity to sodium chloride or glucose solutions.
• Monitor blood glucose closely in diabetic patients or those receiving concurrent dextrose-containing therapies.
• Avoid rapid bolus administration unless clinically indicated.
• Consider compatibility with other IV medications; incompatibility may cause precipitation.
• Verify correct vial integrity and expiration date before use.

Glucosa Y Cloruro De Sodio may interact with other intravenous agents, affecting safety or efficacy.

Avoid

• Co‑administration with hypertonic saline solutions that could exacerbate hypernatremia.
• Simultaneous infusion of calcium‑containing solutions that may precipitate with phosphate additives.

Use with caution

• Concurrent dextrose‑containing medications, which can increase risk of hyperglycemia.
• Diuretic therapy, which may alter electrolyte balance during infusion.
• Blood products, requiring separate line or flushing to prevent incompatibility.